Evidence map›Paper›PMID 36360560›Full record

ArticleHealthcare (Basel, Switzerland)2022

Vascular Risk Factors in Ischemic Stroke Survivors: A Retrospective Study in Catalonia, Spain.

Silvia Reverté-Villarroya, Rosa Suñer-Soler, Jose Zaragoza-Brunet, Gisela Martín-Ozaeta, Patricia Esteve-Belloch, Iago Payo-Froiz, Esther Sauras-Colón, Fidel Lopez-Espuela

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Silvia Reverté-VillarroyaNursing Department, Universitat Rovira Virgili, Avenue Remolins, 13-15, 43500 Tortosa, Spain.ORCID 0000-0002-2052-9978
Rosa Suñer-SolerFaculty of Nursing, University of Girona, Emili Grahit, 77, 17071 Girona, Spain.ORCID 0000-0002-7928-9112
Jose Zaragoza-BrunetHospital de Tortosa Verge de la Cinta, ICS, IISPV, C/Esplanetes no 14, 43500 Tortosa, Spain.
Gisela Martín-OzaetaHospital de Tortosa Verge de la Cinta, ICS, IISPV, C/Esplanetes no 14, 43500 Tortosa, Spain.
Patricia Esteve-BellochHospital de Tortosa Verge de la Cinta, ICS, IISPV, C/Esplanetes no 14, 43500 Tortosa, Spain.
Iago Payo-FroizHospital de Tortosa Verge de la Cinta, ICS, IISPV, C/Esplanetes no 14, 43500 Tortosa, Spain.
Esther Sauras-ColónHospital de Tortosa Verge de la Cinta, ICS, IISPV, C/Esplanetes no 14, 43500 Tortosa, Spain.
Fidel Lopez-EspuelaMetabolic Bone Diseases Research Group, Nursing Department, Occupational Therapy College, University of Extremadura, Avenue of the University s/n, 10003 Cáceres, Spain.ORCID 0000-0002-7509-1192
Hospital Universitari de Tortosa Verge de la Cinta · ESUniversidad de Extremadura · ESUniversitat de Girona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The distribution of vascular risk factors (VRFs) and stroke management vary by geographic area. Our aim was to examine the percentage of the VRFs according to age and sex in ischemic stroke survivors in a geographical area on the Mediterranean coast of Southern Catalonia, Spain. Methods: This was a multicenter, observational, retrospective, community-based study of a cohort, the data of which we obtained from digital clinical records of the Catalan Institute of Health. The study included all patients with a confirmed diagnosis of ischemic stroke who were treated between 1 January 2011 and 31 December 2020. Patients met the following inclusion criteria: residing in the study area, age ≥ 18 years, and presenting ≥1 modifiable vascular risk factor. The exclusion criteria were as follows: death patients (non-survivors) and patients without modifiable VRFs. We collected the demographic, clinical, and VRF variables of the total of 2054 cases included, and we analyzed the data according to age groups, sex, and number of VRFs. Results: Most of the patients included were in the 55−80 age group (n = 1139; 55.45%). Of the patients, 56.48% (n = 1160) presented ≤ 2 modifiable VRFs, and the age group <55 years old (67.01%) presented more VRFs. Hypertension and (>80 years old (38.82%)) and dyslipidemia (<55 years (28.33%)) were the most prevalent VRFs. In the age group 55−80 (69.59% men), the prevalence of VRFs was higher ((3−4 VRF (42.76%) and >4 VRF (5.35%)). Conclusions: These results suggest the presence of many VRFs in people diagnosed with ischemic stroke—although with a lower percentage compared to other studies—and the need for specific individualized interventions for the control of modifiable RFs related to primary and secondary prevention of stroke.

Indexed as

epidemiologyischemic strokerisk factorsrural populationsex differencessurvivors

Identifiers

PMID36360560
PMCPMC9690451
OpenAlexW4308531321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.